Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials.
OBJECTIVES: The use of clinical staging in the fatal neurodegenerative disease amyotrophic lateral sclerosis would have value in optimising future therapeutic trials. We aimed to use previous clinical trial data to determine the length of time patients spend in each of four proposed stages, its rang...
Hlavní autoři: | Balendra, R, Jones, A, Jivraj, N, Steen, I, Young, C, Shaw, P, Turner, M, Leigh, P, Al-Chalabi, A |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2015
|
Podobné jednotky
-
Use of clinical staging in amyotrophic lateral sclerosis for phase 3 clinical trials
Autor: Balendra, R, a další
Vydáno: (2015) -
Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
Autor: Jones, A, a další
Vydáno: (2014) -
Estimating clinical stage of amyotrophic lateral sclerosis from the ALS Functional Rating Scale.
Autor: Balendra, R, a další
Vydáno: (2014) -
Validation of an Amyotrophic Lateral Sclerosis Staging System Using Clinical Trial Data
Autor: Jones, A, a další
Vydáno: (2013) -
Multi-Centre Clinical Trial Data Using the King's Amyotrophic Lateral Sclerosis (ALS) Staging System
Autor: Balendra, R, a další
Vydáno: (2013)